Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C11orf42 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | PCSK6 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | PUM1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | PHOSPHO1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | KIF15 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | HOXD4 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | TLE3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | HIST1H3G | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | FRMD4B | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | IREB2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |